ALEMBICLTDNSEAlembic Limited· PharmaceuticalsHighNeutral
Announced Tue, 13 May · 18:14 IST

Alembic Limited has informed the Exchange regarding 'Intimation for Amendments Code of Practicesand Procedures for Fair Disclosure of Unpublished Price SensitiveInformation '.

Emphasis Of MatterRevenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Alembic Limited announced audited financial results for Q4 and FY ended March 31, 2025. Consolidated revenue from operations rose to Rs. 22,189 lakhs from Rs. 15,749 lakhs (up ~41% YoY), while standalone net profit jumped to Rs. 14,195 lakhs from Rs. 9,289 lakhs (up ~53% YoY). The Real Estate segment was the key growth driver, with revenue climbing to Rs. 18,967 lakhs from Rs. 12,574 lakhs, while the API business stayed broadly flat at Rs. 3,221 lakhs. The Board recommended a dividend of Rs. 2.40 per share (120%) for FY25, same as last year. M/s Samdani Shah & Kabra was appointed as Secretarial Auditor for five years (FY26–FY30). The auditor (CNK & Associates LLP) issued an unmodified opinion but flagged an Emphasis of Matter regarding a disputed electricity duty matter involving a Rs. 2,052 lakh provision and a Rs. 3,500 lakh deposit with the Supreme Court.

Likely market impact

Strong earnings growth, especially in the Real Estate segment, and a maintained 120% dividend signal robust shareholder returns. The pending electricity duty dispute remains a watch item, though the Supreme Court appeal has been admitted, reducing near-term risk. Overall, the results are positive for shareholders.